Trial Profile
A Phase 1, Single Center, Double-blind, Placebo-Controlled, Dose Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Effects of Multiple Oral Doses of AEF0117 in Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs AEF 0117 (Primary)
- Indications Substance-related disorders
- Focus Adverse reactions
- Sponsors Aelis Farma
- 18 Jun 2018 Status changed from recruiting to completed.
- 26 Feb 2018 New trial record